← back to search

Andrea Cossarizza

Istituto Nazionale di Fisica Nucleare, Centro Nazionale Analisi Fotogrammi · IT
Area of research
Virology · Immunology
Research interest
Research interests include HIV Research and Treatment, Immune Cell Function and Interaction, HIV-related health complications and treatments, and COVID-19 Clinical Research Studies.
h-index
93
citations
41,988
works
644
NIH funding
primary concept
Medicine
email

Recent publications

Smallpox-specific T cells in vaccinated centenarians exhibit different phenotypic and metabolic traits of long-term memory compared to SARS-CoV-2-specific memory T cells.
2026cited by 0position: contributordoi
Cytomics-driven insights for investigating host–pathogen interactions
hLife 2026cited by 0position: contributordoi
Optimizing High-Parameter T-Cell Immunophenotyping Through Direct Comparison of Conventional and Spectral Flow Cytometry
2026cited by 0position: contributordoi
Sepsis in patients who are immunocompromised: diagnostic challenges and future therapies
The Lancet Respiratory Medicine 2025cited by 29position: middledoi
Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells.
2025cited by 3position: contributordoi
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions.
2024cited by 49position: contributordoi
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients.
2024cited by 16position: contributordoi
SARS-CoV-2 Vaccination Responses in Anti-CD20-Treated Progressive Multiple Sclerosis Patients Show Immunosenescence in Antigen-Specific B and T Cells.
2024cited by 2position: contributordoi
Airborne pathogens diffusion: A comparison between tracer gas and pigmented aerosols for indoor environment analysis.
2024cited by 0position: contributordoi
B- and T-cell Specific Responses to Vaccination against SARS-CoV-2 in Anti-CD20 Treated Patients with Relapsing-Remitting or Progressive Form of Multiple Sclerosis Reveal Immunosenescent Features
2024cited by 0position: contributordoi
Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer
2024cited by 0position: contributordoi
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
The Lancet Respiratory Medicine 2023cited by 174position: middledoi
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
Nature Communications 2023cited by 72position: lastdoi
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis.
2023cited by 54position: contributordoi
Reduced Graphene Oxide Electrolyte‐Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti‐Drug Antibodies
Advanced Materials 2023cited by 29position: middledoi
Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions.
2023cited by 27position: contributordoi
Africa-specific human genetic variation near CHD1L associates with HIV-1 load
Nature 2023cited by 25position: middledoi
A Comprehensive Analysis of Cytokine Network in Centenarians.
2023cited by 22position: contributordoi
Pillars of long-term antiretroviral therapy success
Pharmacological Research 2023cited by 20position: middledoi
Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
2023cited by 17position: contributordoi
Healthy preterm newborns: Altered innate immunity and impaired monocyte function.
2023cited by 7position: contributordoi
Reduced Graphene Oxide Electrolyte-Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti-Drug Antibodies.
2023cited by 7position: contributordoi
The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients.
2023cited by 1position: contributordoi
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
2023cited by 0position: contributordoi
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis (RAP-ALS study)
2023cited by 0position: contributordoi
Metabolic pathways engaged by antigen-specific T and B cells after SARS-CoV-2 vaccination in multiple sclerosis patients on different immunomodulatory drugs reveal immunosenescence and predict vaccine efficacy.
2023cited by 0position: contributordoi
Metabolic reprograming shapes neutrophil functions in severe COVID-19.
2022cited by 58position: contributordoi
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.
2022cited by 37position: contributordoi
4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells.
2022cited by 30position: contributordoi
The interplay of post-acute COVID-19 syndrome and aging: a biological, clinical and public health approach
Ageing Research Reviews 2022cited by 30position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 49 papers (2019–2026)Sara De Biasi · University of Modena and Reggio Emilia28 papers (2014–2026)Lara Gibellini · University of Modena and Reggio Emilia27 papers (2013–2026) · 21 papers (2021–2026) · 20 papers (2021–2026) · 15 papers (2020–2026)Marcello Pinti · Honey bee and Silkworm Research Unit14 papers (2019–2023)Massimo Girardis · University of Modena and Reggio Emilia14 papers (2019–2024)Marianna Meschiari · University of Modena and Reggio Emilia12 papers (2020–2024)Giovanni Guaraldi · Morpho (United States)9 papers (2019–2022) · 8 papers (2019–2022)Milena Nasi · University of Modena and Reggio Emilia6 papers (2021–2023) · 6 papers (2014–2023)Marco Mattioli · Centro Specialistico Nutrizionale (Nuben Srl) c/o Sani Medical Center Castellalto (TE)5 papers (2020–2022)Fabio Facchinetti · University of Modena and Reggio Emilia5 papers (2020–2022) · 5 papers (2014–2019)Paolo Pinton · Tufts University5 papers (2014–2019)Anna Vittoria Mattioli · Marymount University4 papers (2020–2022)Alin Liviu Ciobanu · Clarivate PLC4 papers (2024–2024)Martina Cardi · University of Modena and Reggio Emilia4 papers (2024–2025)